Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Solomon

Showing results (131-140 of 622) with videos related to

Pageof 63
Sort By:
Pharmacoepidemiology and Drug Safety|September 24, 2004
Statin lipid-lowering drugs and bone mineral densityDaniel H Solomon, Joel S Finkelstein, Philip S Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 31, 2022
Arthritis & Rheumatology: "Mid-Term" ReportDaniel H Solomon, Richard Bucala, Mariana J Kaplan, et al.
Arthritis Research & Therapy|January 30, 2014
DMARD non-use in low-income, elderly rheumatoid arthritis patients: results of 86 structured interviewsErika M Brown, Katie L Garneau, Hsun Tsao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 4, 2024
"Rounding Third Base and Heading Home": Arthritis & Rheumatology in 2024Daniel H Solomon, Mariana J Kaplan, Peter A Nigrovic, et al.
Seminars in Arthritis and Rheumatism|November 19, 2024
Defining immune cell phenotypes that distinguish treatment responders and non-responders in RAKathryne E Marks, Alice Horisberger, Daniel H Solomon, et al.
Pharmacoepidemiology and Drug Safety|June 1, 2011
Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic "matrix design"Jeremy A Rassen, Daniel H Solomon, Robert J Glynn, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 15, 2011
Kidney function and long-term medication adherence after myocardial infarction in the elderlyTara I Chang, Manisha Desai, Daniel H Solomon, et al.
The Journal of Clinical Endocrinology and Metabolism|July 8, 2011
The economics of improving medication adherence in osteoporosis: validation and application of a simulation modelAmanda R Patrick, John T Schousboe, Elena Losina, et al.
The American Journal of Medicine|November 26, 2008
Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injuryWolfgang C Winkelmayer, Sushrut S Waikar, Helen Mogun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2014
Alcohol consumption and risk of incident rheumatoid arthritis in women: a prospective studyBing Lu, Daniel H Solomon, Karen H Costenbader, et al.
Pageof 63

Showing results (131-140 of 622) with videos related to

Sort By:
Pageof 63
Pharmacoepidemiology and Drug Safety|September 24, 2004
Statin lipid-lowering drugs and bone mineral densityDaniel H Solomon, Joel S Finkelstein, Philip S Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 31, 2022
Arthritis & Rheumatology: "Mid-Term" ReportDaniel H Solomon, Richard Bucala, Mariana J Kaplan, et al.
Arthritis Research & Therapy|January 30, 2014
DMARD non-use in low-income, elderly rheumatoid arthritis patients: results of 86 structured interviewsErika M Brown, Katie L Garneau, Hsun Tsao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 4, 2024
"Rounding Third Base and Heading Home": Arthritis & Rheumatology in 2024Daniel H Solomon, Mariana J Kaplan, Peter A Nigrovic, et al.
Seminars in Arthritis and Rheumatism|November 19, 2024
Defining immune cell phenotypes that distinguish treatment responders and non-responders in RAKathryne E Marks, Alice Horisberger, Daniel H Solomon, et al.
Pharmacoepidemiology and Drug Safety|June 1, 2011
Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic "matrix design"Jeremy A Rassen, Daniel H Solomon, Robert J Glynn, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 15, 2011
Kidney function and long-term medication adherence after myocardial infarction in the elderlyTara I Chang, Manisha Desai, Daniel H Solomon, et al.
The Journal of Clinical Endocrinology and Metabolism|July 8, 2011
The economics of improving medication adherence in osteoporosis: validation and application of a simulation modelAmanda R Patrick, John T Schousboe, Elena Losina, et al.
The American Journal of Medicine|November 26, 2008
Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injuryWolfgang C Winkelmayer, Sushrut S Waikar, Helen Mogun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2014
Alcohol consumption and risk of incident rheumatoid arthritis in women: a prospective studyBing Lu, Daniel H Solomon, Karen H Costenbader, et al.
Pageof 63